Lv13
60 积分 2025-10-10 加入
Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial
7小时前
已完结
Vesicular monoamine transport inhibitors: current uses and future directions
7小时前
已完结
Tardive dyskinesia in Chinese patients with schizophrenia: Prevalence, clinical correlates and relationship with cognitive impairment
2天前
已完结
Long term course and outcome of first episode schizophrenia: a 27-to-31-year follow-up
11天前
已完结
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia
11天前
已完结
Place of evidence-based medicine in the diagnosis of mental disorders
11天前
已完结
Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)
11天前
已完结
The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta‐analysis
17天前
已完结
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies
17天前
已完结
Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysis
20天前
已完结
皖公网安备34019202002308
